期刊文献+

腹膜透析相关性腹膜炎的致病菌及其易感因素分析 被引量:11

Analysis of pathogens and predisposing factors in peritoneal dialysis-associated peritonitis
原文传递
导出
摘要 目的分析第四军医大学西京医院腹膜透析中心腹膜透析相关性腹膜炎的易感因素、致病菌谱、药敏情况及预后。方法回顾性分析第四军医大学西京医院腹膜透析中心2013年7月至2015年6月持续性非卧床腹膜透析(CAPD)患者中腹膜透析相关性腹膜炎(PDAP)患者及未发生腹膜炎的腹膜透析患者的透析龄(〈1年组,1~3年组,〉3年组)、文化程度(初中以下组、初中及初中以上组)、培训者工龄(〈5年组,5~10年组,〉10年组)及血清白蛋白水平等临床资料;同时分析腹膜透析相关性腹膜炎患者致病菌谱、药敏等临床资料及转归情况。结果 501例CAPD患者中,87例患者发生106例次腹膜炎,平均腹膜炎发生率为1次/66.8病人月。透析龄〈1年组,1~3年组,〉3年组的腹膜炎发生率分别为18.8%(21/112)、24.0%(56/233)、6.4%(10/156),三组间差异有统计学意义(χ^2=20.42,P〈0.001);初中以下文化水平患者腹膜炎发生率(29.1%,59/203)显著高于初中及以上文化水平患者(12.4%,37/298)(χ^2=21.60,P〈0.001);培训护士的工龄〈5年,5~10年和〉10年组,腹膜炎的发生率分别为25.4%(51/201)、15.4%(23/148)、8.6%(13/152),三组间比较差异有统计学意义(χ^2=17.55,P〈0.001)。腹膜炎患者的血清白蛋白水平[(26.89±5.16)g/L]显著低于非腹膜炎组[(34.58±6.27)g/L;t=-8.8,P〈0.001]。腹膜炎患者透出液病原菌培养阳性率为58.3%(56/96),革兰阳性菌比例为78.6%(44/56)。革兰阴性菌中大肠埃希菌占45.5%(5/11)。头孢唑林钠、头孢他啶的经验用药有效率为65.9%(70/106)。表皮葡萄球菌感染共21例次,66.7%(14/21)复发,33.3%(7/21)拔管。结论本中心的腹膜透析相关性腹膜炎的发生率与患者透析龄、文化程度、培训者工龄及血清白蛋白水平密切相关。腹膜炎致病菌以革兰阳性菌为主,其中表皮葡萄球菌所占比例最高,且复发率和拔管率高。 Objective To analyze the predisposing factors, pathogen spectrum, antibiotic sensitivity,and prognosis in peritoneal dialysis-associated peritonitis( PDAP) patients of Xijing Hospital Affiliated to Fourth Military Medical University. Methods A retrospective analysis was made of clinical data including PD time( 1 year,1-3 years,and 3 years groups),education level( under junior high school,junior high school and above groups),trainers seniority( 5 years,5-10 years, 10 years groups),serum albumin level,the spectrum of pathogens,antibiotic sensitivity,outcomes,and others,in continuous ambulatory peritoneal dialysis( CAPD) patients with or without PDAP of the Peritoneal Dialysis Centre in Xijing Hospital Affiliated to Fourth Military Medical University from July 2013 to June 2015.Results Among the 501 CAPD patients,87 patients suffered from PDAP for 106 times,with an average PDAP incidence of once per 66. 8 patient-month. In the PD time 1 year group,1-3 years group,and 3 years group,the incidence rates of PDAP were 18. 8%( 21 /112),24. 0%( 56 /233),and 6. 4%( 10 /156),respectively,with significant differences among the three groups( χ^2= 20. 42,P 0. 001); the incidence rate of PDAP in the group with education level under junior high school( 29. 1%,59 /203) was significantly higher than that of the group with education level of junior high school and above( 12. 4%,37 /298)( χ^2= 21. 60,P 0. 001); and in the trainer seniority low than 5 years group,5-10 years group,and above 10 years group,the incidence rates of PDAP were 25. 4%( 51 /201),15. 4%( 23 /148),and8. 6%( 13 /152),respectively,with significant differences among the three groups( χ^2= 17. 55,P 0. 001). The level of serum albumin in the group with PDAP( 26. 89 ± 5. 16 g / L) was significantly lower than that in the group without PDAP( 34. 58 ± 6. 27 g / L)( t =- 8. 8,P 0. 001). Results of culture from peritoneal fluid indicated that the positive rates of pathogenic microorganisms and gram-positive bacteria were58. 3%( 56 /96) and 78. 6%( 44 /56),respectively; and among gram-negative bacilli,the percentage of Eescherichia coli was 45. 5%( 5 /11). The effective rate of empirical use of cefazolin sodium and ceftazidime was 65. 9%( 70 /106). Staphylococcus epidermidis infection occurred in 21 cases,with relapse in 14 cases( 66. 7%) and extubation in 7 cases( 33. 3%). Conclusion The incidence of PDAP in this centre closely correlated with PD time,education level,trainer seniority,and serum albumin. Gram-positive bacteria played a dominant role in the pathogenic microorganisms of PDAP, in which Staphylococcus epidermidis was of the highest percentage with high rates of both relapse and extubation.
出处 《中华肾病研究电子杂志》 2016年第3期118-122,共5页 Chinese Journal of Kidney Disease Investigation(Electronic Edition)
基金 国家自然科学基金(81470993 81272621) 百特公司腹膜透析专项课题(CHN-RENAL-IIS-2012-039)
关键词 腹膜透析 腹膜炎 致病菌 易感因素 Peritoneal dialysis Peritonitis Pathogenic bacteria Predisposing factors
  • 相关文献

参考文献14

  • 1Li PK, Szeto CC, Piraino B, et al. Peritoneal dialysis-related infections recommendations: 2010 update [ J]. Perit Dial Int, 2010, 30(4) : 393-423.
  • 2陈香美.腹膜透析标准操作规程[M].北京:人民军医出版社,2011:101.
  • 3Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States [ J ]. JAMA, 2007, 298 (17) : 2038- 2047.
  • 4Fried LF, Bernardini J, Johnston JR, et al. Peritonitis influences mortality in peritoneal dialysis patients [ J ]. J Am Soc Nephrol, 1996, 7(10): 2176-2182.
  • 5Figueiredo AE, De Figueiredo CE, D'Avila D. Peritonitis prevention in CAPD: to mask or not [Jl. Perit Dial Int, 2000, 20(3) : 354- 358.
  • 6朱伟平,崔彤霞,徐庆东,李中和,张桦.腹膜透析相关性腹膜炎的菌谱及其药敏分析[J].中国血液净化,2011,10(7):357-359. 被引量:20
  • 7文锐,宁建平.腹膜透析相关感染性腹膜炎病原菌及耐药性分析[J].肾脏病与透析肾移植杂志,2009,18(6):533-536. 被引量:18
  • 8许戎,胡宁,阿荣其其格,李孜,董捷.腹膜透析相关性腹膜炎单中心8年变化趋势回顾分析[J].中国血液净化,2013,12(1):37-41. 被引量:20
  • 9Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections [ J]. Science, 1999, 284 (5418) : 1318-1322.
  • 10Finkelstein ES. Jekel J, Troidle L, et al. Patterns of infection in patients maintained on long term peritoneal dialysis therapy with multiple episodes of peritonitis [ J ]. Am J Kidney Dis, 2002, 39 (6) : 1278-1286.

二级参考文献48

  • 1余学清.中国腹膜透析的现状及我们的应对之策[J].中华肾脏病杂志,2004,20(6):389-390. 被引量:24
  • 2陈林,郭群英,阳晓,姜宗培,陈崴,毛海萍,余学清.腹膜透析相关性真菌性腹膜炎20例临床分析[J].中国血液净化,2006,5(10):710-713. 被引量:18
  • 3郭群英,陈林,阳晓,杨念生,冯敏,姜宗培,毛海萍,陈崴,余学清.腹膜透析相关感染性腹膜炎致病菌及菌谱变化——单个腹膜透析中心15年回顾分析[J].中华肾脏病杂志,2006,22(12):719-724. 被引量:64
  • 4倪军,童孟立,崔杏成.72例次持续性非卧床腹透腹膜炎分析[J].中国中西医结合肾病杂志,2007,8(4):217-219. 被引量:24
  • 5Bender FH,Bernardini J,Piraino B. Prevention of infectious complications in peritoneal dialysis: best demonstrated practices. Kidney Int, (Suppl) 2006,103:44 - 54.
  • 6Keane WF, Bailie GR, Boeschoten E,et al. Adult peritoneal dialysisrelated peritonitis treatment recommendations: 2000 update. Petit Dial Int ,2000,20 : 396 -411.
  • 7Piraino B, Baille GR, Bernardini J, et al. Peritoneal dialysis related infections recommendations: 2005 update. Perit Dial Int, 2005,25 (2): 107 - 131.
  • 8Furgeson SB ,Teitelbaum L New Treatment Options and Protocols for Peritoneal Dialysis-Related Peritonitis. Contrib Nephrol, 2009,163 : 169 - 176.
  • 9Kan GW,Thomas MA, Heath CH. A 12-month rewiew of peritoneal dialysis-related peritonitis in western australia:Is empiric vancomnycin still indicated for some patients? Petit Dial Int,2003,23: 465 -468.
  • 10Kabat-Koperska J, Col embiewska E, Ciechanowski K. Peritoneal dialysis-related peritonitis in the years 2005-2007 among patients of the Peritoneal Dialysis Clinic of the Department of Neparology, Transplantology and Internal Medicine, Pmneranian Medical University in Szczecin. Pol Arch Med Wewn,2008,118(12) : 694 -699.

共引文献100

同被引文献71

引证文献11

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部